申请人:Gilead Sciences, Inc.
公开号:US20160108030A1
公开(公告)日:2016-04-21
Compounds of formula (I) or salts thereof are disclosed. Also disclosed are pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I and therapeutic methods for treating a Retroviridae viral infection including an infection caused by the HIV virus.
本发明揭示了化学式(I)的化合物或其盐。还揭示了包括化合物I的制药组合物、制备化合物I的方法、制备化合物I有用的中间体以及治疗逆转录病毒感染的治疗方法,包括由HIV病毒引起的感染。